home / stock / bmed / bmed news


BMED News and Press, BLACKROCK ETF TRUS From 01/25/23

Stock Information

Company Name: BLACKROCK ETF TRUS
Stock Symbol: BMED
Market: NYSE

Menu

BMED BMED Quote BMED Short BMED News BMED Articles BMED Message Board
Get BMED Alerts

News, Short Squeeze, Breakout and More Instantly...

BMED - Healthy Outlook For Therapeutics

Summary Even in its battered condition, the therapeutics sub-sector still accounts for 9.1% of the Russell 2000 Growth index. M&A activity continues to heat up as big players—currently flush with cash—look to drive growth by filling their development pipelines. In ...

BMED - More Volatility Ahead? Buckle Up With Defensive Equities

Summary Last year’s market volatility was driven primarily by uncertainty over inflation and interest rates. In last year’s downturn, technology stocks were at the epicenter of market volatility. After years of steady gains, investors now acknowledge that technology stocks...

BMED - Healthcare Stocks: An Innovative Antidote For Volatile Times

Summary Healthcare stocks have remained in vogue through volatile markets, driven by increased interest in the sector during COVID-19. During a painful year for equity investors in 2022, healthcare stocks offered a pocket of relative stability. Global healthcare stocks ended the yea...

BMED - Can Health Care Stocks Outperform Again In 2023?

Summary How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector. How staff shortages in the health care sector may also impact investors. Health care managed to outperform the S&P 500 last yea...

BMED - Investment Strategy Monthly Insights, December 2022

Summary The top two mega themes in terms of global net inflows in 2022 were Climate Change-related themes and Big Data. The largest net outflows came from tech-heavy themes, led by Robotics & Automation. 2023 may bring a return to more normal markets driven by economics rather t...

BMED - Why Earnings Revisions May Mean More To Markets Than Recession Worries

Why the economy, practically speaking, may already be in recession. Why defensive sectors may be worth a closer look in the current environment. Market sentiment might be bearish, but that doesn't mean there aren't opportunities. Aggressive moves by central banks...

BMED - Taking Stock: Q3 2022 Equity Market Outlook

The first five months of the year marked the worst start for the S&P 500 since 1970 ― and the sixth worst back to 1928. Stock valuations have come down, but company earnings remain solid. Earnings will slow, but 20% is hard to imagine, even in a recession. For fur...

BMED - Shifting Opportunities In An Atypical Landscape

How similar will the next three or five years look from the years that immediately preceded the pandemic? And what are the implications for us as global equity investors? We don’t expect anything like the hyperinflation and stagflation we experienced in the 1970s; our outlook s...

BMED - agilon health Sets Stage For 2022 Growth

agilon health went public in April 2021, raising approximately $1 billion in an IPO. The firm provides health care services to Medicare Advantage patients in the United States. AGL has laid the foundation for further growth and potential profitability, so I'll wait and see if they...

BMED - argenx SE: Again Following Dutch Biotech, Prior Recommendation Near-Term Gain

Derivatives markets, used by the market-making community to hedge equity market liquidity trade orders, tell by their component structure and prices the subject stock’s expected coming price range limits. By comparing today’s balance of upside and downside price change p...

Previous 10 Next 10